Abstract
We used a dual-color fluorescence in situ hybridization technique to estimate deleted mitochondrial DNA at a single-cell level and determine any correlation with the disease progression in lymphocytes from patients with Pearson marrow-pancreas syndrome. The method demonstrated a shift in heteroplasmy, paralleling the hematologic improvement.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anemia, Sideroblastic / blood
-
Anemia, Sideroblastic / genetics*
-
DNA, Mitochondrial / blood*
-
Female
-
Hematopoietic Stem Cells / pathology
-
Humans
-
In Situ Hybridization, Fluorescence / methods*
-
Infant
-
Lymphocytes
-
Pancreatic Diseases / blood
-
Pancreatic Diseases / genetics*
-
Syndrome